We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
MGP is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
181.4
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
5626.3
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
1924.1
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
1391.2
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
1292.1
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
1033.8
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
992.6
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
935.7
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
920.6
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
894.3
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
836.3
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
817.2
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
758.3
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
741.1
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
735.5
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
676.2
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
673.7
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
659.5
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
631.9
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
608.5
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
587.2
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
585.6
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
511.9
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
510.7
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
496.2
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
489.7
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
479.0
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
449.0
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
446.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
421.4
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
418.5
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
404.1
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
398.8
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
393.0
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
387.2
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
385.9
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
385.0
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
371.7
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
370.9
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
369.3
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
353.2
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
334.1
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
329.7
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
323.7
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
305.2
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
300.7
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
300.5
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
296.6
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
285.6
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
274.4
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
267.7
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
265.7
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
263.7
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
260.4
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
258.7
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
248.0
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
237.1
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
237.0
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
235.2
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
234.5
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
228.6
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
226.3
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
224.0
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
219.4
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
218.9
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
218.8
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
218.5
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
210.8
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
210.4
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
209.9
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
207.6
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
201.3
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
201.2
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
200.3
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
199.5
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
198.1
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
197.5
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
194.9
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
194.3
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
193.3
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
186.1
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
183.3
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
179.1
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
178.0
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
177.2
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
172.6
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
170.2
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
169.1
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
168.8
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
168.3
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
167.6
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
166.1
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
165.7
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
164.8
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
163.6
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
160.1
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
158.1
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
155.5
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
155.2
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
154.2
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
152.1
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
151.4
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
150.2
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
149.6
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
148.3
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
147.7
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
145.2
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
143.6
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
142.5
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
141.7
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
140.2
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
140.1
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
137.8
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
137.1
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
136.7
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
136.6
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
136.2
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
134.8
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
133.7
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
133.2
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
132.2
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
131.7
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
131.3
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
127.6
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
127.4
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
126.8
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
125.7
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
125.3
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
124.7
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
124.5
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
123.9
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
123.7
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
123.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
122.7
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
121.1
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
120.6
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
119.3
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
119.2
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
117.9
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
117.9
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
117.4
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
117.2
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
116.7
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
116.5
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
116.3
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
114.2
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
113.7
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
113.6
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
113.4
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
113.1
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
112.0
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
112.0
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
112.0
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
111.1
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
110.8
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
110.5
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
109.1
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
108.9
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
107.4
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
107.4
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
107.0
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
106.4
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
105.8
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
104.1
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
101.8
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
101.6
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
101.4
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
100.8
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
100.0
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
99.9
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
99.8
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
99.1
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
98.0
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
96.9
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
96.6
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
96.3
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
95.8
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
94.4
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
94.3
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
93.9
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
90.9
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
90.6
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
90.3
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
89.1
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
87.4
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
87.3
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
85.9
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
85.7
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
85.6
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
85.4
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
85.2
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
85.1
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
85.1
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
84.7
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
84.6
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
84.5
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
84.3
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
83.2
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
82.8
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
82.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
82.3
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
81.9
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
81.5
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
80.8
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
80.7
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
80.1
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
80.0
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
78.9
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
78.5
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
78.5
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
78.1
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
77.8
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
77.6
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
77.1
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
76.9
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
76.9
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
76.6
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
76.6
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
75.5
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
75.3
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
73.7
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
73.7
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
73.7
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
73.6
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
73.6
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
73.0
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
71.4
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
71.3
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
71.2
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
70.7
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
70.4
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
69.6
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
68.7
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
68.5
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
68.4
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
67.6
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
67.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
67.5
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
67.5
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
67.3
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
67.0
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
67.0
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
66.7
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
66.3
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
65.8
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
65.3
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
65.2
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
64.9
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
64.3
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
64.1
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
63.9
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
63.1
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
62.4
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
60.6
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
60.5
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
60.5
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
60.3
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
60.2
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
60.0
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
59.6
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
59.5
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
59.4
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
57.7
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
57.1
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
56.9
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
56.7
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
56.7
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
55.7
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
55.4
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
54.9
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
54.7
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
54.4
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
54.3
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
54.2
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
53.6
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
53.4
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
52.3
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
52.2
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
51.8
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
51.6
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
50.6
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
50.5
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
50.0
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
49.8
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
49.6
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
49.5
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
48.0
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
47.8
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
47.7
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
47.4
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
46.9
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
46.2
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
46.0
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
45.4
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
44.8
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
44.1
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
44.0
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
44.0
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
43.7
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
43.3
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
43.1
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
43.0
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
42.7
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
42.0
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
40.8
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
40.5
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
40.1
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
39.6
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
38.4
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
38.1
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
37.9
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
37.7
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
37.1
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
37.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
36.9
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
36.9
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
36.3
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
36.1
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
35.7
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
35.7
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
34.7
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
34.6
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
34.4
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
34.3
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
32.9
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
32.1
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
32.0
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
32.0
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
31.8
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
31.8
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
31.7
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
31.1
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
30.6
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
29.9
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
29.7
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
28.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
28.6
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
26.0
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
25.7
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
25.3
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
25.2
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
25.0
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
23.8
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
22.3
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
21.7
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
19.4
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
16.6
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
16.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
15.4
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
MGP is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
84.1
Number of samples
81
Samples
Sample
Description
TPM
DO46591
0 years, female, NA, stage:III, dead, 195 days
483.2
DO46331
0 years, female, NA, stage:III, dead, 612 days
399.9
DO46571
0 years, female, NA, stage:III, dead, 243 days
301.2
DO46581
0 years, female, NA, stage:III, dead, 408 days
282.0
DO46453
0 years, female, NA, stage:III, dead, 3294 days
247.6
DO46329
0 years, female, NA, stage:III, dead, 1699 days
213.7
DO46368
0 years, female, NA, stage:III, dead, 2879 days
197.5
DO46538
0 years, female, NA, stage:III, dead, 1527 days
195.3
DO46602
0 years, female, NA, stage:III, dead, 205 days
183.9
DO46366
0 years, female, NA, stage:III, dead, 2054 days
178.6
DO46597
0 years, female, NA, stage:III, dead, 393 days
177.4
DO46551
0 years, female, NA, stage:III, dead, 1055 days
158.6
DO46443
0 years, female, NA, stage:III, dead, 2464 days
154.7
DO46340
0 years, female, NA, stage:III, dead, 616 days
148.7
DO46576
0 years, female, NA, stage:III, alive, 133 days
129.6
DO46408
0 years, female, NA, stage:III, dead, 489 days
129.4
DO46398
0 years, female, NA, stage:III, alive, 437 days
126.3
DO46388
0 years, female, NA, stage:III, dead, 413 days
120.7
DO46344
0 years, female, NA, stage:III, dead, 642 days
107.5
DO46350
0 years, female, NA, stage:III, dead, 886 days
99.9
DO46586
0 years, female, NA, stage:III, dead, 1019 days
94.2
DO46528
0 years, female, NA, stage:III, alive, 6139 days
91.1
DO46508
0 years, female, NA, stage:III, dead, 2101 days
90.9
DO46386
0 years, female, NA, stage:III, dead, 1162 days
88.0
DO46412
0 years, female, NA, stage:III, dead, 597 days
86.5
DO46332
0 years, female, NA, stage:III, dead, 689 days
81.4
DO46566
0 years, female, NA, stage:III, dead, 673 days
73.0
DO46588
0 years, female, NA, stage:III, dead, 438 days
71.4
DO46518
0 years, female, NA, stage:III, alive, 2960 days
68.0
DO46382
0 years, female, NA, stage:IV, dead, 311 days
66.9
DO46448
0 years, female, NA, stage:III, dead, 654 days
65.6
DO46342
0 years, female, NA, stage:III, dead, 1398 days
60.0
DO46330
0 years, female, NA, stage:III, dead, 684 days
59.9
DO46380
0 years, female, NA, stage:III, dead, 1423 days
58.6
DO46364
0 years, female, NA, stage:III, dead, 806 days
56.7
DO46348
0 years, female, NA, stage:IV, dead, 287 days
56.6
DO46356
0 years, female, NA, stage:III, dead, 911 days
56.0
DO46493
0 years, female, NA, stage:IV, alive, 839 days
54.7
DO46362
0 years, female, NA, stage:III, dead, 1639 days
54.6
DO46325
0 years, female, NA, stage:III, dead, 477 days
54.2
DO46346
0 years, female, NA, stage:III, dead, 1187 days
54.0
DO46334
0 years, female, NA, stage:III, dead, 496 days
53.5
DO46352
0 years, female, NA, stage:III, dead, 677 days
53.2
DO46372
0 years, female, NA, stage:III, dead, 1326 days
53.1
DO46358
0 years, female, NA, stage:III, dead, 423 days
52.3
DO46546
0 years, female, NA, stage:III, dead, 1889 days
50.6
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
50.4
DO46376
0 years, female, NA, stage:III, dead, 1430 days
47.8
DO46402
0 years, female, NA, stage:III, dead, 511 days
46.7
DO46333
0 years, female, NA, stage:III, dead, 359 days
46.5
DO46436
0 years, female, NA, stage:III, alive, 3193 days
45.3
DO46560
0 years, female, NA, stage:IV, dead, 286 days
44.8
DO46468
0 years, female, NA, stage:III, alive, 2776 days
42.1
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
40.2
DO46463
0 years, female, NA, stage:III, dead, 2451 days
39.7
DO46404
0 years, female, NA, stage:III, dead, 690 days
38.4
DO46378
0 years, female, NA, stage:III, alive, 843 days
36.9
DO46396
0 years, female, NA, stage:III, dead, 583 days
35.8
DO46336
0 years, female, NA, stage:IV, dead, 664 days
35.8
DO46392
0 years, female, NA, stage:III, dead, 628 days
35.4
DO46390
0 years, female, NA, stage:III, dead, 374 days
34.3
DO46328
0 years, female, NA, stage:III, dead, 972 days
33.1
DO46338
0 years, female, NA, stage:III, dead, 596 days
32.3
DO46354
0 years, female, NA, stage:III, dead, 843 days
32.2
DO46568
0 years, female, NA, stage:III, dead, 320 days
29.2
DO46561
0 years, female, NA, stage:III, dead, 195 days
28.4
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
28.0
DO46370
0 years, female, NA, stage:III, dead, 1727 days
27.4
DO46533
0 years, female, NA, stage:III, alive, 3667 days
26.9
DO46432
0 years, female, NA, stage:III, alive, 2218 days
26.3
DO46384
0 years, female, NA, stage:III, dead, 614 days
25.1
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
23.5
DO46611
0 years, female, NA, stage:III, dead, 734 days
19.1
DO46606
0 years, female, NA, stage:III, alive, 804 days
18.1
DO46326
0 years, female, NA, stage:III, dead, 701 days
17.4
DO46327
0 years, female, NA, stage:III, dead, 184 days
17.4
DO46400
0 years, female, NA, stage:III, dead, 719 days
17.1
DO46374
0 years, female, NA, stage:III, dead, 1409 days
16.7
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
13.6
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
13.4
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
11.9
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
3.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
3.2
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
3.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
3.0
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
2.8
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
2.7
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
2.4
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
2.2
a3a26070-fb84-406a-8280-d555e6_D2
Normal
2.0
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
1.9
340a3769-3031-41ae-bb08-a2f696_D2
Normal
1.8
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.7
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
1.7
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
1.5
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
1.4
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
1.4
a65d8e76-640f-4341-a561-afbb57_D2
Normal
1.3
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
1.3
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
1.2
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
1.1
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
1.1
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
1.1
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
1.1
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
1.0
2f901c90-617e-46da-9fac-d68369_D2
Tumor
1.0
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
1.0
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.9
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.8
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.8
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.8
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.8
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.7
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.7
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.7
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.7
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.7
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.6
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.6
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.6
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.6
1db5574d-aca7-403c-8100-6e705f_D2
Normal
0.6
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.5
1772e913-f62e-446a-8cf3-720348_D2
Tumor
0.5
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.5
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.5
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.3
15524912-685a-47ce-a824-567848_D2
Tumor
0.3
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.3
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.3
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.2
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.2
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.2
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.2
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.1
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.1
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.0
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.0
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.1
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.1
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.1
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.1
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.1
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.1
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.2
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.2
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.2
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-0.2
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.3
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.3
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-0.3
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-0.3
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.4
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.4
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.4
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.4
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.5
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.5
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-0.5
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.6
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.6
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.8
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.8
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.8
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.8
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.9
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.9
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.9
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-1.0
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-1.0
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-1.0
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-1.0
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-1.1
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-1.2
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-1.2
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-1.2
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-1.2
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-1.4
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-1.6
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-1.7
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-1.9
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.